To assess the benefits and harms of the anterior approach compared with those of conventional liver resection in patients with hepatocellular carcinoma.
This is a protocol.
Anterior approach versus conventional liver resection for hepatocellular carcinoma
You may also be interested in:
- No evidence to evaluate the potential benefits and harms of cryotherapy in the treatment of hepatocellular carcinoma
- Postoperative adjuvant transarterial (chemo)embolisation after liver resection for hepatocellular carcinoma
- Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in advanced chronic liver disease
- Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma
- Percutaneous ethanol injection for the treatment of early liver cancer